Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy

Prathyusha Konda, Liubov M. Lifshits, John A. Roque, Houston D. Cole, Colin G. Cameron, Sherri A. McFarland, Shashi Gujar

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Abstract

We report a new class of ruthenium (Ru)-based photosensitizers that induce potent cytotoxicity in melanoma cells following activation with NIR light. In addition to the direct cytotoxic effect, this Ru-based photodynamic therapy induces immunogenic cell death in melanoma cells that can be therapeutically exploited to establish protective antitumor immunity.

Original languageEnglish
Article number1863626
JournalOncoImmunology
Volume10
Issue number1
DOIs
Publication statusPublished - 2021

Bibliographical note

Funding Information:
This work was supported via the National Cancer Institute (NCI) of the National Institutes of Health (NIH)’s Award R01CA222227 to S.A.M. and S.G. The content in this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Publisher Copyright:
© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Immunology
  • Oncology

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural

Fingerprint

Dive into the research topics of 'Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy'. Together they form a unique fingerprint.

Cite this